While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitisZORYVE, a next-generation topical phosphodiesterase-4 ...

The FDA has extended the review period for the sNDA for tapinarof cream, 1% in the treatment of atopic dermatitis.

Dermatologists have warned that applying adult skincare products and alcohol-based creams on babies puts them at risk of skin ...

Air pollution harms not just our internal organs but also our skin, potentially causing various skin diseases. Different skin ...

Q) I’VE had a rash on my forehead for six months. For the first couple, I used a steroid cream but was then told not to any ...

Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...

It is also recommended that patients reduce their use of facial moisturizers, night creams, and make-ups (Weber, 2003) and discontinue whitening and tartar-control toothpastes. POD in adults is ...

Skin conditions are more common than you might think, with perioral dermatitis being one of the most prevalent. You've likely ...

Does your skin feel as dry as a desert no matter how much moisturiser you use? It’s time to step up your skincare game.

PHAT is a facial rejuvenation therapy that combines nanofat and its stem cells with PRP for anti-aging that lasts for more ...

The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.